Cargando…
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients
Introduction. There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. There is evidence that HOMA-adiponectin (HOMA-AD) is more accurate, but its role in HCV patients is unknown. The purpose of this study was to evaluate IR in an HCV sample and contro...
Autores principales: | Michalczuk, Matheus Truccolo, Kappel, Camila Rippol, Birkhan, Oscar, Bragança, Ana Carolina, Álvares-da-Silva, Mário Reis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405643/ https://www.ncbi.nlm.nih.gov/pubmed/22848841 http://dx.doi.org/10.1155/2012/576584 |
Ejemplares similares
-
The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016) -
Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome
por: Hussein, Shamim Riadh Mohammed, et al.
Publicado: (2023) -
HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients
por: Grasso, Alessandro, et al.
Publicado: (2015) -
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018) -
Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)